These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4760900)

  • 1. The relationship between the dose of warfarin, free drug in plasma, and its elimination in the bile of rats.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):943-50. PubMed ID: 4760900
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of novibiocin and tolbutamide on the excretion of warfarin in the bile of rats.
    Wosilait WD; Eisenbrandt LL
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):109-16. PubMed ID: 4686095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rodenticidal action of warfarin/4th communication: Binding to serum albumin of mice and rats (author's transl)].
    von Oettingen U; Niedner R; Meyer F
    Arzneimittelforschung; 1975 Nov; 25(11):1705-6. PubMed ID: 1243077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oxyphenbutazone on the excretion of 14 C-warfarin in the bile of rat.
    Wosilait WD; Eisenbrandt LL
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):413-20. PubMed ID: 5074533
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple factors affecting excretion of warfarin in rats.
    Pepper ES; Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):275-81. PubMed ID: 918347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hepatic uptake on the disappearance of warfarin from the plasma of rats: a kinetic analysis.
    Covell DG; Abbrecht PH; Berman M
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):127-45. PubMed ID: 6886970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of glycyrrhizin in normal and albumin-deficient rats.
    Koga K; Tomoyama M; Ohyanagi K; Takada K
    Biopharm Drug Dispos; 2008 Oct; 29(7):373-81. PubMed ID: 18548521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium salicylate on the fate of warfarin in the rat.
    Coldwell BB; Buttar HS; Paul CJ; Thomas BH
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):374-84. PubMed ID: 4851695
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of the intestinal microflora on the elimination of warfarin in the rat.
    Remmel RP; Pohl LR; Elmer GW
    Drug Metab Dispos; 1981; 9(5):410-4. PubMed ID: 6117438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in protein binding of diflunisal.
    Lin JH
    Drug Metab Dispos; 1989; 17(2):221-3. PubMed ID: 2565215
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological disposition of 2,6-dimethyl-4-benzyl-4-demethylrifampicin in rats, mice, and dogs.
    Wolpert MK; Lu K; Derr CJ; Loo TL; Johns DG
    Drug Metab Dispos; 1974; 2(3):237-46. PubMed ID: 4153001
    [No Abstract]   [Full Text] [Related]  

  • 14. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of warfarin influences the acid-base equilibrium of H242 in sudlow site I of human serum albumin.
    Perry JL; Goldsmith MR; Williams TR; Radack KP; Christensen T; Gorham J; Pasquinelli MA; Toone EJ; Beratan DN; Simon JD
    Photochem Photobiol; 2006; 82(5):1365-9. PubMed ID: 16563025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.
    Sellers EM; Koch-Weser J
    N Engl J Med; 1970 Oct; 283(16):827-31. PubMed ID: 5458032
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin.
    O'Reilly RA
    J Clin Invest; 1969 Jan; 48(1):193-202. PubMed ID: 5765021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intersubject variation of warfarin binding to protein in serum of normal subjects.
    Yacobi A; Stoll RG; DiSanto AR; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):743-6. PubMed ID: 959669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model solution for intestinal absorption of warfarin. A drug with non-linear distribution pharmacokinetics in the rat.
    Julkunen RJ; Kekki M; Wahlström B
    Arzneimittelforschung; 1980; 30(2):264-7. PubMed ID: 7378103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.